Bioactive reinforcing bioink for hybrid bioprinting of implantable bone
The project aims to develop 'BioForceInk,' a bioactive bioink for hybrid 3D bioprinting of vascularized bone implants, enhancing mechanical strength and biological functionality for clinical applications.
Projectdetails
Introduction
3D bioprinting is an emerging technique that offers promise for fabricating implantable tissues. Despite significant advancements, the field struggles to replicate the mechanical robustness and biological complexity of native tissues, particularly in applications requiring high mechanical strength such as bone.
Project Overview
This proposal introduces 'BioForceInk,' a bioactive reinforcing bioink designed for direct bioprinting alongside a cell-laden hydrogel within a cell-conductive environment. The microparticle-based bioink is printable at room temperature and solidifies at 37°C, forming a stiff, porous scaffold within the construct.
Preliminary Studies
Our preliminary studies demonstrated its excellent printability, mechanical properties, and osteoconductive capabilities in a hybrid bioprinting context.
Objectives
To enhance vascularized bone differentiation in vitro and support bioprinted implant integration and bone recovery in vivo, the bioink will be enriched with osteogenic and vasculogenic factors.
- Develop the growth factor-loaded BioForceInk.
- Utilize it for creating vascularized bone implants by hybrid bioprinting in tandem with cell-laden soft bioink.
- Evaluate the regenerative potential of the bioprinted vascularized bone implants in a critical-size bone loss model.
- Test the technology with industrial partners and prepare it for commercialization by the end of the project.
Innovation and Potential
BioForceInk offers a unique combination of mechanical support and biological activity that facilitates the single-step fabrication of physiologically relevant bone implants. This innovation has the potential to significantly narrow the gap between bioprinting technology and clinical application, contributing to the development of personalized, mechanically robust, and biologically functional bone implants.
Future Applications
With its tunable properties, BioForceInk could be further adapted for bioprinting of various tissues, reflecting its broad potential across the field.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-9-2024 |
Einddatum | 28-2-2026 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGYpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Human based bioinks to engineer physiologically relevant tissuesHumanINK aims to validate human-based bioinks for 3D bioprinting, creating advanced cell culture environments to enhance drug development and reduce reliance on animal testing. | ERC Proof of... | € 150.000 | 2022 | Details |
A novel support material for 3D bioprinting and post-printing tissue growth: Print and GrowThe "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications. | ERC Proof of... | € 150.000 | 2022 | Details |
A 3D-printable biomimetic bone regeneration materialPRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes. | ERC Proof of... | € 150.000 | 2024 | Details |
4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogelsmorphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth. | ERC Starting... | € 1.499.906 | 2023 | Details |
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticlesThe NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release. | ERC Proof of... | € 150.000 | 2024 | Details |
Human based bioinks to engineer physiologically relevant tissues
HumanINK aims to validate human-based bioinks for 3D bioprinting, creating advanced cell culture environments to enhance drug development and reduce reliance on animal testing.
A novel support material for 3D bioprinting and post-printing tissue growth: Print and Grow
The "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications.
A 3D-printable biomimetic bone regeneration material
PRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes.
4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels
morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles
The NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicineThe SILKink project aims to develop a silk-based bioink for 3D printing bone marrow tissue models to enhance stem cell culture and advance drug development and personalized medicine. | EIC Transition | € 2.494.687 | 2023 | Details |
Better Bioprinting by Light-sheet LithographyB-BRIGHTER aims to develop a novel high-speed bioprinting technology for creating complex engineered tissues, enhancing drug testing and therapeutic applications while fostering healthcare innovation. | EIC Transition | € 2.093.331 | 2022 | Details |
PRInted Symbiotic Materials as a dynamic platform for Living Tissues productionPRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications. | EIC Pathfinder | € 2.805.403 | 2022 | Details |
Ceramic paste for 3D-printable bone implantsZ3DLABS en Delft Solids Solutions ontwikkelen een 3D printbare keramische pasta voor patiëntspecifieke, bio-compatibele botimplantaten met een langere levensduur en lagere behandelkosten. | Mkb-innovati... | € 195.510 | 2020 | Details |
High-throughput ultrasound-based volumetric 3D printing for tissue engineeringSONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research. | EIC Pathfinder | € 2.999.625 | 2025 | Details |
Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine
The SILKink project aims to develop a silk-based bioink for 3D printing bone marrow tissue models to enhance stem cell culture and advance drug development and personalized medicine.
Better Bioprinting by Light-sheet Lithography
B-BRIGHTER aims to develop a novel high-speed bioprinting technology for creating complex engineered tissues, enhancing drug testing and therapeutic applications while fostering healthcare innovation.
PRInted Symbiotic Materials as a dynamic platform for Living Tissues production
PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.
Ceramic paste for 3D-printable bone implants
Z3DLABS en Delft Solids Solutions ontwikkelen een 3D printbare keramische pasta voor patiëntspecifieke, bio-compatibele botimplantaten met een langere levensduur en lagere behandelkosten.
High-throughput ultrasound-based volumetric 3D printing for tissue engineering
SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.